Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pimozide in acute schizophrenia: a pilot study.

D Garton, T Silverstone

    Current Medical Research and Opinion
    |January 1, 1979
    PubMed
    Summary

    Pimozide effectively treated acute schizophrenia symptoms in a pilot study. Eight of ten patients showed favorable responses, enabling hospital discharge.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Drugs and driving.

    British journal of clinical pharmacology·2012
    Same author

    Menstrual cycle effects on the action of buspirone on food intake in healthy female volunteers.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    A double-blind placebo-controlled study of rolipram in depressed in-patients.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Neurochemical and psychoanalytical approaches to mania.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Sumatriptan challenge in bipolar patients with and without migraine: a neuroendocrine study of 5-HT1D receptor function.

    International clinical psychopharmacology·2002
    Same author

    Serotonin and bipolar disorder.

    Journal of affective disorders·2001

    Area of Science:

    • Psychiatry
    • Pharmacology

    Background:

    • Acute schizophrenia presents a range of severe symptoms requiring effective treatment.
    • Pimozide, a diphenylbutylpiperidine derivative, was investigated for its therapeutic potential.

    Observation:

    • A pilot study involved 10 patients diagnosed with acute schizophrenia.
    • Patients presented with frank symptoms indicative of an acute psychotic episode.

    Findings:

    • Eight out of ten patients demonstrated a favorable response to oral pimozide.
    • Therapeutic effects were observed at daily doses ranging from 12 to 40 mg.
    • Symptom improvement occurred within 1 to 5 weeks, allowing for patient discharge.

    Implications:

    • Oral pimozide shows promise as an effective treatment for acute schizophrenia.
    • The study supports pimozide's efficacy across the spectrum of acute schizophrenic symptoms.
    • Further research into pimozide dosage and long-term effects is warranted.

    Related Experiment Videos